Projected impact of 2026 ACC/AHA/Multisociety Dyslipidemia Guideline on lipid-lowering therapy eligibility based on Class 1 and 2a recommendations

Journal of Clinical Lipidology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles